About HistoGeneX
HistoGeneX is a company based in Kluisbergen (Belgium) founded in 2001 was acquired by Arsenal Capital Partners in July 2019. HistoGeneX has completed 1 acquisition, including Mosaic Laboratories. HistoGeneX offers products and services including CellEngine® Software, Flow Cytometry, and Olink™ PEA Technology. HistoGeneX operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Kluisbergen, Belgium
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1.8 M (USD), Grant
May 31, 2014
-
Investors
Arsenal Capital Partners
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Arsenal Capital Partners
(Jul 31, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HistoGeneX
HistoGeneX offers a comprehensive portfolio of products and services, including CellEngine® Software, Flow Cytometry, and Olink™ PEA Technology.
Platform for comprehensive cytometry analysis in research.
Service for cellular phenotyping and immune monitoring.
Quantifies protein biomarkers using minimal sample volumes.
Funding Insights of HistoGeneX
Investors in HistoGeneX
HistoGeneX has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Arsenal Capital Partners and Beste Online Casino België.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments target specialty industrials and healthcare sectors.
|
Locked | Locked | Locked | |
|
A platform for online casino gaming in Belgium is provided.
|
Locked | Locked | Locked |
Investor details for HistoGeneX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HistoGeneX
HistoGeneX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Mosaic Laboratories.
Investment portfolio details for HistoGeneX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Laboratory focused on providing pre-clinical and clinical trial services to pharma and biotech sector
|
Locked | Locked | 2005 | Locked |
Complete acquisition details for HistoGeneX
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - HistoGeneX
Detailed financials for HistoGeneX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Histogenex Comparisons
Peer comparison for HistoGeneX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HistoGeneX
HistoGeneX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
Detailed competitors of HistoGeneX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Histogenex
Complete news archive for HistoGeneX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HistoGeneX
HistoGeneX was founded in 2001 and raised its 1st funding round 13 years after it was founded.
HistoGeneX is headquartered in Kluisbergen, Belgium. It is registered at Kluisbergen, East Flanders, Belgium.
Founded in 2001 and based in Kluisbergen, Belgium, the company operates in the biotechnology sector with a focus on oncology. Technologies are developed to analyze DNA, RNA, and proteins for categorizing and understanding cancer. Specialization occurs in immune-oncology biomarkers, where the immune system within the tumor microenvironment is assessed through pathology and molecular biology methods.
HistoGeneX's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
HistoGeneX offers CellEngine® Software, Flow Cytometry, and Olink™ PEA Technology.
HistoGeneX has made 1 acquisition, including Mosaic Laboratories.
HistoGeneX has 2 investors. Key investors include Arsenal Capital Partners, and Beste Online Casino België.